RGLS
NASDAQ
$8.16
Regulus Therapeutics Inc (RGLS)
Market Cap
$540M
Free Cash Flow Yield
-8.08%
Price Chart
Valuation
Market Cap$540M
P/S0.57
P/B7.82
Profitability
EBITDA-$51M
Profit Margin-26.4%
Operating Margin-20.6%
EPS-$0.76
Financial Health
Free Cash Flow Yield-8.08%
Growth & Risk
Sharpe Ratio1.24